Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United States
  4. Nyse
  5. DaVita Inc.
  6. Summary
    DVA   US23918K1088

DAVITA INC.

(DVA)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nyse
10/12/2021 10/13/2021 10/14/2021 10/15/2021 10/18/2021 Date
110.74(c) 109.96(c) 111.47(c) 112.21(c) 110.7 Last
786 899 730 464 802 724 682 525 106 690 Volume
-0.72% -0.70% +1.37% +0.66% -1.35% Change
More quotes
Estimated financial data (e) (USD)
Sales 2021 11 569 M - -
Net income 2021 1 001 M - -
Net Debt 2021 9 857 M - -
P/E ratio 2021 12,3x
Yield 2021 1,26%
Sales 2022 12 069 M - -
Net income 2022 968 M - -
Net Debt 2022 10 216 M - -
P/E ratio 2022 11,9x
Yield 2022 1,31%
Capitalization 11 760 M 11 760 M -
EV / Sales 2021 1,87x
EV / Sales 2022 1,82x
Nbr of Employees 67 000
Free-Float 92,6%
More Financials
Company
DaVita Inc., formerly DaVita HealthCare Partners Inc., operates one division: DaVita Kidney Care (Kidney Care). The Kidney Care division consists of the Company's United States dialysis and related lab services, its ancillary services and strategic initiatives, including its international operations, and its corporate administrative support. The Company's segments include U.S. dialysis and related lab services and... 
More about the company
Ratings of DaVita Inc.
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
B-
More Ratings
All news about DAVITA INC.
10/13DAVITA : Truist Securities Adjusts DaVita's Price Target to $125 from $145, Keeps Hold Rat..
MT
10/11DAVITA : Climate Action Goals Approved by the Science Based Target Initiative
PR
10/08FOOD FACTS FRIDAY : Persimmons
PU
10/06DAVITA : “Limiting” Vs. “Avoiding” Foods
PU
09/28GO WITH YOUR GUT : CKD and Gut Health
PU
09/16DAVITA KIDNEY CARE : Names New Chief Nursing Officer
PR
09/13DAVITA : How to get support during Hurricane Nicholas
PU
09/09DAVITA INC. : Change in Directors or Principal Officers (form 8-K)
AQ
09/09DAVITA : Cowen Initiates DaVita With Market Perform Rating, $145 Price Target
MT
09/09DAVITA : Announces Dr. Gregory Moore to Join its Board of Directors
PR
09/09DaVita Inc. Appoints Gregory Moore to its Board of Directors and to Serve on its Nomina..
CI
08/13NORTH AMERICAN MORNING BRIEFING : Blockbuster -3-
DJ
08/12DAVITA : Barclays Downgrades DaVita to Equal-Weight From Overweight, Adjusts Price Target ..
MT
08/09DAVITA : Insiders Make Significant Stock Sales in DaVita (DVA) Shares Extending the Trend ..
MT
08/06INSIDER TRENDS : DaVita Insider Extends 90-Day Selling Trend
MT
More news
News in other languages on DAVITA INC.
07/16MÄRKTE EUROPA/Kaum Bewegung bei Aktien - Jenoptik sehr fest
2019FRESENIUS/FMC IM FOKUS : Auf Kurs - Mit Risiken und Nebenwirkungen
2019AKTIE IM FOKUS : FMC unter schwächsten Dax-Werten - Sorgen um US-Dialysegeschäft
2019US-Apothekenkette CVS will in den Heimdialyse-Markt - FMC-Aktie unter Druck
2019Aktien Frankfurt: Moderate Verluste - Anlegern fehlt weiter der Mut zum Kauf
More news
Analyst Recommendations on DAVITA INC.
More recommendations
Chart DAVITA INC.
Duration : Period :
DaVita Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends DAVITA INC.
Short TermMid-TermLong Term
TrendsBearishBearishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 10
Last Close Price 112,21 $
Average target price 138,11 $
Spread / Average Target 23,1%
EPS Revisions
Managers and Directors
Javier J. Rodriguez Chief Executive Officer & Director
Joel Ackerman Chief Financial Officer
Pamela M. Arway Chairman
Jeff Giullian Chief Medical Officer
James O. Hearty Chief Compliance Officer
Sector and Competitors